Wouters J - Search Results

1

3,6-disubstituted coumarins as mechanism-based inhibitors of thrombin and factor Xa.

Frédérick R, Robert S, Charlier C, de Ruyck J, Wouters J, Pirotte B, Masereel B, Pochet L. Frédérick R, et al. Among authors: wouters j. J Med Chem. 2005 Dec 1;48(24):7592-603. doi: 10.1021/jm050448g. J Med Chem. 2005. PMID: 16302799

2

Structural aspects of monoamine oxidase and its reversible inhibition.

Wouters J. Wouters J. Curr Med Chem. 1998 Apr;5(2):137-62. Curr Med Chem. 1998. PMID: 9481038 Review.

3

Design, synthesis, and anticonvulsant activity of 1-(pyrid-3-ylsulfonamido)-2-nitroethylenes.

Masereel B, Wouters J, Pochet L, Lambert D. Masereel B, et al. Among authors: wouters j. J Med Chem. 1998 Aug 13;41(17):3239-44. doi: 10.1021/jm981022n. J Med Chem. 1998. PMID: 9703469

4

Molecular lipophilicity potential by CLIP, a reliable tool for the description of the 3D distribution of lipophilicity: application to 3-phenyloxazolidin-2-one, a prototype series of reversible MAOA inhibitors.

Ooms F, Wouters J, Collin S, Durant F, Jegham S, George P. Ooms F, et al. Among authors: wouters j. Bioorg Med Chem Lett. 1998 Jun 2;8(11):1425-30. doi: 10.1016/s0960-894x(98)00230-3. Bioorg Med Chem Lett. 1998. PMID: 9871778

5

A reversible monoamine oxidase A inhibitor, befloxatone: structural approach of its mechanism of action.

Wouters J, Moureau F, Evrard G, Koenig JJ, Jegham S, George P, Durant F. Wouters J, et al. Bioorg Med Chem. 1999 Aug;7(8):1683-93. doi: 10.1016/s0968-0896(99)00102-9. Bioorg Med Chem. 1999. PMID: 10482460

6

Antagonism of the TXA2 receptor by seratrodast: a structural approach.

Wouters J, Durant F, Masereel B. Wouters J, et al. Bioorg Med Chem Lett. 1999 Oct 4;9(19):2867-70. doi: 10.1016/s0960-894x(99)00490-4. Bioorg Med Chem Lett. 1999. PMID: 10522708

7

Coumarinic derivatives as mechanism-based inhibitors of alpha-chymotrypsin and human leukocyte elastase.

Pochet L, Doucet C, Dive G, Wouters J, Masereel B, Reboud-Ravaux M, Pirotte B. Pochet L, et al. Among authors: wouters j. Bioorg Med Chem. 2000 Jun;8(6):1489-501. doi: 10.1016/s0968-0896(00)00071-7. Bioorg Med Chem. 2000. PMID: 10896125 Free article.

8

Terbogrel, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition.

Michaux C, Norberg B, Dogné JM, Durant F, Masereel B, Delarge J, Wouters J. Michaux C, et al. Among authors: wouters j. Acta Crystallogr C. 2000 Oct;56 ( Pt 10):1265-6. doi: 10.1107/s0108270100009872. Acta Crystallogr C. 2000. PMID: 11025320

9

Isosterism among analogues of torasemide: conformational, electronic and lipophilic properties.

Wouters J, Michaux C, Durant F, Dogné JM, Delarge J, Masereel B. Wouters J, et al. Eur J Med Chem. 2000 Oct;35(10):923-9. doi: 10.1016/s0223-5234(00)01174-0. Eur J Med Chem. 2000. PMID: 11121618

10

Structure determination and comparison of BM567, a sulfonylurea, with terbogrel, two compounds with dual action, thromboxane receptor antagonism and thromboxane synthase inhibition.

Michaux C, Rolin S, Dogné JM, Durant F, Masereel B, Delarge J, Wouters J. Michaux C, et al. Among authors: wouters j. Bioorg Med Chem Lett. 2001 Apr 23;11(8):1019-22. doi: 10.1016/s0960-894x(01)00114-7. Bioorg Med Chem Lett. 2001. PMID: 11327579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

749 results

Search Page

Filters